再鼎医药一季度总收入同比增长22% 股价上涨超7%

iDoNews
09 May

5月9日,再鼎医药(09688)早盘持续走高,股价上涨7.16%,报23.95港元。公司公布2025年第一季度业绩,总收入达1.06亿美元,同比增长22.19%;研发开支为6072.9万美元,同比增加11.13%。其中,产品收入净额为1.057亿美元,同比增长21%,主要得益于卫伟迦、则乐和纽再乐销售额的提升。

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10